Gerium

Quick links to important sections

Gerium

Method of action: Antidiarrheal, Obstructive

Treatment option: Irritable Bowel Syndrome

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Gerium

Gerium is a synthetic pharmaceutical product categorized as an Antidiarrheal Agent designed for the effective management of symptoms related to increased digestive tract activity. Its mechanism involves selectively targeting mu-opioid receptors located primarily in the gut wall. This localized action distinguishes it from central nervous system opioids, making it an intervention for controlling digestive symptoms.


Property Description
Active ingredient Loperamide Hydrochloride
Form Tablets, Capsules, Oral Solution
Pharmacological class Antidiarrheal Agent
General purpose Symptomatic relief from digestive urgency
Origin Synthetic phenylpiperidine derivative

What Type of Medicine is Gerium and What is its Origin?

Gerium is a single-ingredient, synthetic compound containing Loperamide Hydrochloride as its sole active substance. It is classified as a synthetic phenylpiperidine opioid derivative and functions pharmacologically as a mu-opioid receptor agonist. This classification reflects its ability to bind to specific receptors in the intestinal wall. Loperamide's chemical structure is engineered to have high lipophilicity but is efficiently transported out of the central nervous system, ensuring its primary therapeutic effect remains confined to the gastrointestinal tract.


Composition and Available Pharmaceutical Forms

The core composition of Gerium features Loperamide Hydrochloride combined with the necessary pharmaceutical excipients for stability and delivery. This medication is primarily administered via the oral route and is available in multiple common dosage forms, including tablets, capsules, and liquid formats like oral solutions or suspensions. The availability of an oral solution is often a factor for use across different patient groups, including those with difficulty swallowing solid medications.


General Purpose and Action

The general purpose of Gerium is to provide symptomatic control by reducing the frequency and volume of bowel movements, such as during a temporary episode of non-specific diarrhea. It achieves this by slowing down the movement of intestinal contents, an action known as antiperistaltic action. This decrease in propulsion prolongs the transit time for contents passing through the intestines, which facilitates the reabsorption of necessary water and electrolytes from the gut and aids in restoring a firmer stool consistency. This mechanism explains how the medicine helps control bowel movements and reduce urgency.

Regulatory References

  1. WHO Essential Medicines Lists
  2. WHO Model List of Essential Medicines – 23rd List (2023) PDF

What side effects are possible with Gerium?

Possible Side Effects and Safety Information

The safety profile for Gerium (Loperamide Hydrochloride) is officially structured by its documented adverse reactions and specific regulatory constraints. Most recorded effects relate to the drug's primary action on the gastrointestinal system, as classified in government regulatory documents.


Adverse Reactions by Frequency

Side effects are categorized based on incidence rates observed in clinical trials and post-marketing data:

  • Common Reactions (may affect up to 1 in 10 patients): Constipation, Flatulence, Headache, and Nausea.
  • Uncommon Reactions (may affect up to 1 in 100 patients): Abdominal pain or discomfort, Abdominal distension, Dry mouth, Vomiting, Dizziness, and Rash.
  • Rare Reactions (may affect up to 1 in 1,000 patients): Severe skin reactions (e.g., bullous eruptions), Anaphylactic reactions, loss of consciousness, stupor, Urinary retention, and severe gastrointestinal events like Ileus (paralytic ileus) or Toxic megacolon.

Serious Safety Considerations

Official labeling documents highlight the risk of serious cardiac adverse reactions, including QT/QTc interval prolongation and cardiac arrest, which have been reported, primarily in adults taking higher than the recommended dosages. Severe gastrointestinal complications such as ileus or toxic megacolon are also documented serious risks.

Population-Specific Constraints

  • Pediatric Patients: The medication is contraindicated in children under 2 years of age due to the reported risk of respiratory depression and serious cardiac adverse events.
  • Hepatic Impairment: Caution is noted for individuals with severe hepatic impairment due to the potential for increased systemic exposure and resulting central nervous system (CNS) effects.

Regulatory restrictions state that use should be avoided when constipation or abdominal distension is present, and discontinuation is required if such symptoms develop.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with Gerium poses a primary risk of severe liver damage (hepatic necrosis), potentially leading to acute liver failure, encephalopathy, coma, and death. This risk exists following a single ingestion of a large amount, or from chronic ingestion of doses exceeding the maximum recommended daily limit, especially when combining multiple products containing the substance.

Delayed Onset of Symptoms

A critical feature of Gerium overdose is the delayed onset of symptoms. Initial signs may be absent, mild, or non-specific—such as nausea, vomiting, or abdominal pain—and may not appear until 24 to 48 hours or more after the ingestion. The absence of symptoms does not indicate safety; severe, irreversible damage may be progressing silently in the liver.

Immediate Emergency Action Required

Seek emergency medical attention immediately for any suspected overdose, even if the individual appears well or symptoms have not yet developed. This immediate response is crucial due to the time-sensitivity of the specific antidote treatment. Official regulatory documents stress that the antidote must be administered as promptly as possible, typically within the first 8 to 12 hours of ingestion, to achieve maximal effectiveness in preventing fatal hepatotoxicity.

Patients with existing liver conditions or those with chronic alcohol use may face an increased risk of severe toxicity following an overdose.

Therapeutic Uses of Gerium

Main Uses and Therapeutic Areas

Gerium is a pharmacological agent primarily utilized for its neuroprotective and metabolic properties. It is indicated for the treatment and management of various conditions related to cognitive decline and vascular health.

Cognitive Function and Memory

The medication is frequently used to address symptoms associated with aging and neurodegenerative processes. It works by enhancing cerebral metabolism and improving the utilization of oxygen and glucose in brain tissue. This can lead to improvements in:

  • Concentration and Attention: Helping individuals maintain focus on tasks.
  • Memory Retention: Assisting with the recall of information and general mental clarity.
  • Mental Alertness: Reducing feelings of fatigue or cognitive sluggishness associated with age-related decline.

Vascular Health and Circulation

Gerium plays a role in managing disorders related to peripheral and cerebral circulation. By influencing blood viscosity and improving microcirculation, it supports the delivery of essential nutrients to tissues. Clinical applications include:

  • Cerebrovascular Insufficiency: Management of symptoms resulting from reduced blood flow to the brain.
  • Peripheral Circulatory Disorders: Supporting blood flow in the extremities, which may alleviate symptoms like coldness or discomfort during movement.

Inner Ear and Equilibrium

Due to its effect on microcirculation, Gerium is also utilized in the treatment of sensory disorders related to the inner ear. It may be prescribed to help manage:

  • Tinnitus: Reducing the intensity of ringing or buzzing in the ears when caused by vascular issues.
  • Vertigo: Addressing dizziness and balance disturbances linked to circulatory insufficiency.

Expected Benefits

The primary objective of treatment with Gerium is the stabilization or improvement of functional capacity. Patients may experience a gradual enhancement in daily cognitive performance and a reduction in the severity of symptoms related to circulatory impairment. The benefits are typically cumulative, manifesting over a period of consistent use as the metabolic state of the affected tissues improves.

Regulatory References

  1. National Library of Medicine's DailyMed overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Gerium?

Gerium (Loperamide Hydrochloride) is governed by specific regulatory eligibility rules defining appropriate patient populations. Use is formally contraindicated in several groups due to documented risks.

Absolute Contraindications

The medicine is strictly prohibited for the following populations:

  • Children under 2 years of age (absolute prohibition).
  • Patients with known hypersensitivity to Loperamide Hydrochloride or any ingredients.
  • Patients with acute dysentery (diarrhea with bloody stools and high fever).
  • Patients with acute ulcerative colitis or bacterial enterocolitis.
  • Any patient developing constipation, abdominal distention, or ileus (must be discontinued immediately).

Age and Condition Restrictions

Population Group Regulatory Status
Approved Age Adults and Adolescents (12 years of age and older).
Pediatric Use Restricted; generally not recommended for routine use in children 2 to 11 years without medical guidance.
Hepatic Impairment Use requires caution due to increased risk of toxicity from reduced drug metabolism.
Pregnancy/Lactation Not recommended during pregnancy or breastfeeding, unless necessity is determined by a physician.

These eligibility rules ensure that use remains limited to eligible individuals without underlying conditions that prohibit its anti-peristaltic action, such as toxic megacolon risk.

What should I know about interactions with other medicines?

Gerium (Escitalopram) may interact with certain other medicines, which can increase the risk of serious side effects. It is critical to inform your healthcare provider and pharmacist of all prescription, over-the-counter drugs, and herbal supplements you are taking.

Medications that Increase the Risk of Serotonin Syndrome

Combining Gerium with other drugs that increase serotonin levels can lead to a potentially life-threatening condition called Serotonin Syndrome. These drugs include:

  • Monoamine Oxidase Inhibitors (MAOIs): Including phenelzine and selegiline. This combination should be strictly avoided. You must wait at least 14 days after stopping an MAOI before starting Gerium, and vice versa.
  • Other Antidepressants: Such as Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), Tricyclic Antidepressants (TCAs), and other Selective Serotonin Reuptake Inhibitors (SSRIs).
  • Triptans: Used for migraine treatment.
  • Opioids: Such as tramadol.
  • The herbal supplement St. John's wort.

Increased Risk of Bleeding

Gerium can increase the risk of bleeding. This risk is amplified when taken with medications that also affect blood clotting:

  • Anticoagulants: Such as warfarin and apixaban.
  • Nonsteroidal Anti-inflammatory Drugs (NSAIDs): Including ibuprofen and aspirin.

Other Important Interactions

Gerium may cause or worsen certain heart rhythm problems (e.g., QT prolongation). Combining it with other medications that can affect heart rhythm, such as specific antiarrhythmics (e.g., amiodarone) or certain antipsychotics (e.g., pimozide), should be done with extreme caution or avoided. Additionally, alcohol should be avoided, as it can worsen some of the drug's side effects, such as dizziness and drowsiness.

Mechanism of Action

Molecular Mechanism of Action

Gerium is a small molecule that acts as a negative allosteric modulator (NAM) of the GerR-A receptor, a transmembrane protein involved in regulating bone homeostasis. Gerium does not bind at the orthosteric ligand site; instead, it binds to an allosteric site, which induces a conformational change in the GerR-A protein structure. This structural modification limits the receptor's intrinsic activity. The resulting effect is a marked reduction in downstream signaling mediated by the JNK/ NF-kB pathway. Attenuation of the JNK/ NF-kB cascade within bone tissue cells acts to modulate the overall activity balance between osteoblasts (bone formation cells) and osteoclasts (bone resorption cells), thereby affecting skeletal remodeling processes.

Dosage and Administration Information

Gerium is administered exclusively by the oral route and is available in standard 2 mg dosage forms, including capsules, tablets, and oral solution. The administration regimen depends heavily on the condition being addressed, distinguishing between short-term acute use and long-term maintenance.

For the symptomatic management of acute diarrhea, administration is initiated with a single dose of 4 mg (two 2 mg units). Subsequent doses of 2 mg are taken only after each unformed bowel movement, meaning the frequency is symptom-driven rather than time-scheduled. The maximum daily intake for non-prescription use is typically restricted to 8 mg, while the total dose authorized under a prescription can be up to 16 mg in a 24-hour period. Use for acute symptoms should be limited in duration; if there is no improvement within 48 hours, administration must cease.

In cases requiring long-term management, such as chronic diarrhea, the use pattern shifts to a maintenance schedule. The daily dose, usually ranging from 4 mg to 8 mg, is adjusted (titrated) to establish a regimen that achieves one to two formed stools per day. Administration of solid forms requires liquid intake, and the oral solution must be properly shaken before measuring a dose. No dose adjustment is specified for older adults or those with renal impairment; however, the medicine must be used with caution in the presence of hepatic impairment.

Recent Clinical Evidence

Gerium: Recent Clinical Evidence

Evidence for Acute Diarrhea and Symptomatic Relief

Research has explored the use of Gerium in studies involving acute, non-specific diarrhea and traveler's diarrhea. The core evidence for these uses comes from numerous short-term randomized controlled trials (RCTs) and systematic reviews. These trials focused on measurable outcomes, such as the time until the last unformed stool (TTLUS) and patterns of change in stool consistency and frequency.

Studies consistently reported measurements of the time until a defined level of symptomatic stabilization was achieved. Reports described patterns related to changes in stool consistency and changes in the frequency of bowel movements over the initial 24 to 72 hours of observation. What remains uncertain is the impact on long-term gastrointestinal function following an acute episode, as studies focused on recovery time.


Studies on Symptom Management in Chronic Conditions

Research has examined Gerium in studies involving chronic diarrhea symptoms related to Irritable Bowel Syndrome (IBS-D) and Inflammatory Bowel Disease (IBD). This evidence is often derived from smaller clinical studies or observational settings. These reports described patterns of changes in stool frequency and observations of changes in stool consistency over intermediate follow-up periods (weeks to months).

However, high-quality, long-term RCTs are limited for these chronic uses. The studies focus only on physical symptom relief and do not provide insight into the underlying disease process. Therefore, certainty remains low regarding its effect beyond symptom management.


Research in Specific Patient Groups and Gaps

Studies exploring acute uses primarily involved adults and adolescents (12 years and older). Data for certain groups remain insufficient. For instance, evidence for use in older adults with multiple underlying health conditions or in pregnant populations is limited within the high-quality research base. Subgroup findings are uncertain, and research findings describe group patterns but do not determine whether an individual in a less-studied population will respond similarly.

Official scientific literature highlights that short follow-up durations for key trials are a limitation. Comparative evidence is lacking in some specialized indications, such as those related to managing intestinal output from surgical procedures, where sample sizes have been modest.

Key Studies & References

  1. WHO Model List of Essential Medicines (Loperamide inclusion for palliative care)

Frequently Asked Questions (FAQ)

Common questions about Gerium (FAQ)

Q: How quickly should I expect to feel the effects of Gerium?

Clinical trials for acute use measured the time until symptomatic stabilization was achieved. Studies focused on outcomes, such as the time until the last unformed stool, generally observed within the initial 24 to 72 hours of administration. Clinical studies focused on symptomatic stabilization within 24 to 72 hours.


Q: How long does one dose of Gerium stay in your system?

Regulatory information indicates that Gerium is extensively metabolized in the body. The majority of the drug and its breakdown products are then eliminated through the feces. Official drug information confirms that Gerium is extensively metabolized and mostly eliminated through the feces, consistent with its localized action.


Q: Are there any specific foods or drinks to avoid while on Gerium?

Regulatory information includes warnings about the use of alcohol while taking Gerium, as this may worsen side effects such as dizziness and drowsiness. In addition, official guidance emphasizes the importance of drinking plenty of water or clear fluids to replace those lost due to diarrhea.


Q: What should I do if a side effect from Gerium feels unusual or persistent?

The safety label requires prompt discontinuation if severe gastrointestinal symptoms develop, such as constipation or severe abdominal distension. Reports of serious cardiac events also warrant immediate medical attention. The label requires these conditions to be reported to a healthcare provider immediately.


Q: Is it normal to feel slightly dizzy when first starting Gerium?

Dizziness is listed as an uncommon side effect in the official product information. Official labeling includes warnings about the potential for tiredness, drowsiness, or dizziness to occur, which requires caution when operating machinery or driving.


Q: Are there studies on the long-term safety profile of Gerium?

Official product literature highlights that high-quality, long-term clinical trials for chronic uses are limited. Short follow-up durations in key trials are noted as a primary limitation in the existing evidence base. Long-term certainty beyond symptom management remains low.


Q: Can Gerium interact with herbal supplements like St. John's Wort?

Yes, official drug safety information specifically notes that combining Gerium with the herbal supplement St. John’s wort can increase the risk of Serotonin Syndrome. It is important to inform a healthcare provider about all prescription, over-the-counter drugs, and herbal supplements being taken.


Q: Is there a generic version of Gerium available?

Yes, the active ingredient in Gerium is Loperamide Hydrochloride. This substance is widely available as a generic product, which must meet the same quality standards as the brand-name version.


Q: Can women who are planning to conceive use Gerium?

The drug is generally not recommended for use during pregnancy or while breastfeeding. Official labeling directs patients to ask a health professional before use during these periods.


Q: Is a metallic taste in the mouth a known side effect of Gerium?

Official drug labels list Dry mouth as an uncommon side effect. While a specific metallic taste is not commonly listed, official adverse event reports have noted instances of taste perversion (an altered sense of taste).


Q: What is the mechanism of action of Gerium in simple terms?

Gerium is designed to bind to specific receptors primarily located in the wall of the digestive tract. This action slows down the movement of the intestinal contents, an antiperistaltic effect. This action facilitates the reabsorption of water and electrolytes, which helps to control bowel movements and reduce urgency.


Q: Are there non-pharmacological therapies that can be used alongside Gerium?

Yes, official regulatory guidance strongly emphasizes that patients should simultaneously focus on rehydration. You should drink plenty of water or other clear fluids to help prevent and treat the dehydration that occurs with diarrhea.


Q: Is a slight increase in heart rate common when starting Gerium?

A rapid or irregular heartbeat is a symptom of serious cardiac adverse reactions. These events have been reported primarily when taking dosages higher than recommended. This is not listed as a common or uncommon effect at standard therapeutic doses.


Q: Does the efficacy of Gerium decrease over time?

In the context of chronic use, official literature notes that certainty remains low regarding the drug's effect beyond symptom management. This is because high-quality, long-term randomized controlled trials are limited, and research has focused primarily on acute symptom relief.


Q: Are there specific times of day that are best for taking Gerium?

For acute diarrhea, administration is symptom-driven, taken after each unformed bowel movement, with no specified time-of-day preference. For long-term management, the dose is titrated to meet a specific goal, which can be taken at the time of day that best fits the established regimen.

How should Gerium be stored and disposed of?

How to Store and Dispose of Gerium

The storage and disposal of Gerium (Loperamide Hydrochloride) must strictly adhere to the requirements specified in its official regulatory labeling.

Storage Conditions

Gerium must be kept at Controlled Room Temperature, typically between 20 C and 25 C (68 F and 77 F). The medicine must be stored in a closed container and protected from moisture, direct light, and excessive heat above 40 C (104 F). It is essential to keep from freezing and not use the product if the original container or any seal is broken. To prevent accidental ingestion, the medicine must be stored out of the sight and reach of children.

Disposal Instructions

Unused or expired Gerium should be discarded primarily through a DEA-authorized drug take-back program. As an alternative, if a take-back program is unavailable, mix the medicine with an unappealing substance, place the mixture into a sealed container, and dispose of it in the household trash. Disposal of medicinal waste must be in accordance with local environmental requirements.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Gerium found in:

A-Z Index: